| 000 | 01763 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517204725.0 | ||
| 264 | 0 | _c20190729 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1558-3597 | ||
| 024 | 7 |
_a10.1016/j.jacc.2018.01.027 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAriotti, Sara | |
| 245 | 0 | 0 |
_aEffects of Ticagrelor, Prasugrel, or Clopidogrel at Steady State on Endothelial Function. _h[electronic resource] |
| 260 |
_bJournal of the American College of Cardiology _c03 2018 |
||
| 300 |
_a1289-1291 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcute Coronary Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aClopidogrel _xadministration & dosage |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 |
_aPrasugrel Hydrochloride _xadministration & dosage |
| 650 | 0 | 4 |
_aPurinergic P2Y Receptor Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aTicagrelor _xadministration & dosage |
| 700 | 1 | _avan Leeuwen, Maarten | |
| 700 | 1 | _aBrugaletta, Salvatore | |
| 700 | 1 | _aLeonardi, Sergio | |
| 700 | 1 | _aAkkerhuis, K Martijn | |
| 700 | 1 | _aRimoldi, Stefano F | |
| 700 | 1 | _aJanssens, Gladys N | |
| 700 | 1 | _aOrtega-Paz, Luis | |
| 700 | 1 | _aGianni, Umberto | |
| 700 | 1 | _avan den Berge, Jan C | |
| 700 | 1 | _aKaragiannis, Alexios | |
| 700 | 1 | _aWindecker, Stephan | |
| 700 | 1 | _aValgimigli, Marco | |
| 773 | 0 |
_tJournal of the American College of Cardiology _gvol. 71 _gno. 11 _gp. 1289-1291 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jacc.2018.01.027 _zAvailable from publisher's website |
| 999 |
_c28184250 _d28184250 |
||